David Feldshon, M.D., a Yale gastroenterologist who still performs endoscopy two days a week at 75, discusses his approach to ...

Researchers in Lyon, France, conducted a retrospective cohort study of intensifying the dosing of biologics such as Humira, ...

Rybrevant Faspro won accelerated approval for recurrent or metastatic HNSCC after a trial showed a 42% response rate in previously treated patients.

Clinicians have only four limited categories of tools for non-cystic fibrosis bronchiectasis, with little evidence for preventing exacerbations, and the resulting hospitalizations can be lengthy, ...

The second half of our conversation with Christopher Stanley, M.D., MBA, the president of Henry Ford Health's Populance and ...

Expect Democrats to flex their oversight powers even if President Donald Trump’s veto power blocks their efforts to reverse ...

The retail pharmacies will be in one company and Aetna and CVS Caremark, the PBM, in another, according to news reports.

EHRs miss many cancer deaths. Linking electronic health records with claims and third‑party death data sharply improves ...

Health plans should be using data, digital tools and human support to identify potential disruptions early, and whether a ...

Teva’s Weltruza delivers olanzapine monthly under the skin, with no loading doses, oral supplementation or post-injection ...

In the CONNECT trial, CGM users with type 2 diabetes not on insulin saw larger A1C reductions and more time in range than ...

Geisinger Health Plan President Jeremy Gaskill says being owned by a health system aligns incentives, cuts payer-provider ...